Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Bristol Laboratories Ltd

02 10Bristol Myers Squibb

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

REPOTRECTINIB

Brand Name : AUGTYRO

Dosage Form : CAPSULE;ORAL

Dosage Strength : 40MG

Packaging :

Approval Date : 2023-11-15

Application Number : 218213

Regulatory Info : RX

Registration Country : USA

blank

02

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

REPOTRECTINIB

Brand Name : AUGTYRO

Dosage Form : CAPSULE;ORAL

Dosage Strength : 160MG

Packaging :

Approval Date : 2024-06-11

Application Number : 218213

Regulatory Info : RX

Registration Country : USA

blank

03

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Repotrektinib

Brand Name : Augtyro

Dosage Form : Capsule

Dosage Strength : 160mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

04

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Repotrektinib

Brand Name : Augtyro

Dosage Form : Capsule

Dosage Strength : 40mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

05

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Repotrectinib

Brand Name : Augtyro

Dosage Form : Capsule

Dosage Strength : 160mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

06

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Repotrectinib

Brand Name : Augtyro

Dosage Form : Capsule

Dosage Strength : 40mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

07

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Repotrectinib

Brand Name : Augustyro

Dosage Form : Hard Capsules

Dosage Strength : 160mg

Packaging :

Approval Date : 13-01-2025

Application Number : 28107077223

Regulatory Info : Prescription

Registration Country : Denmark

blank

08

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Repotrectinib

Brand Name : Augustyro

Dosage Form : Hard Capsules

Dosage Strength : 40mg

Packaging :

Approval Date : 13-01-2025

Application Number : 28107077123

Regulatory Info : Prescription

Registration Country : Denmark

blank

09

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Repotrektinib

Brand Name : Augtyro

Dosage Form : Capsule

Dosage Strength : 40mg

Packaging :

Approval Date : 13-01-2025

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

10

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Repotrektinib

Brand Name : Augtyro

Dosage Form : Capsule

Dosage Strength : 160mg

Packaging :

Approval Date : 13-01-2025

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

11

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Repotrectinib

Brand Name : Augtyro

Dosage Form :

Dosage Strength :

Packaging : 120

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

12

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Repotrectinib

Brand Name : Augtyro

Dosage Form :

Dosage Strength :

Packaging : 60

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank